Chlorozotocin: phase II evaluation in patients with myeloma.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D013311:Streptozocin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors
D000970:Antineoplastic Agents; C007028:chlorozotocin; D013311:Streptozocin